HCV

Appalachian Partnership to Reduce Disparities (Aim 2)

A Setting Focus Overdose Prevention Intervention

Simplified HCV Integrated Management Model in Methadone Clinics in Ukraine

Hepatitis C Treatment to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior

HIV/HBV/HCV Triple Screening in Primary Care

Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland

The South-East Asian Transgender Health Cohort

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients

Facilitated Telemedicine in the Catholic Health System

Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)

HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking

A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV

Integrated HIV Prevention and HCV Care for PWID

Community Intervention to Eliminate HCV Among People Who Use Drugs.

Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada

The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City

Hepatitis C Treatment in Probation and Parole Office

Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria

Tools to Identify People At Risk or Already Infected with HIV and HCV